Health Care & Life Sciences » Biotechnology | BioRestorative Therapies Inc.

BioRestorative Therapies Inc.

BioRestorative Therapies Inc.
Stock Exchange Other OTC
Market Cap
$4.73 M
Shares Outstanding
17.48 M
Public Float
8.49 M


40 Marcus Drive
Melville New York 11747
United States
Employees -
Updated 07/08/2019
Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. It intends to develop a laboratory, performing cellular characterization and culturing, therapeutic outcomes analysis, stem cell-related IP and stem cell collection and storage services. The company is developing the following scientific initiatives: brtxDISC Program offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures.


View All

Mark Weinreb
Chairman, President, CEO, CFO & CAO
Robert B. Catell
Independent Director